feed,title,long_url,short_url
Benzinga,Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency,https://www.benzinga.com/pressreleases/21/01/n19068838/medicure-announces-pivotal-phase-3-trial-ind-filing-with-fda-for-treatment-of-seizures-associated-,https://j.mp/39cbEBt
Benzinga,Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency,https://www.benzinga.com/pressreleases/21/01/n19068837/medicure-announces-pivotal-phase-3-trial-ind-filing-with-fda-for-treatment-of-seizures-associated-,https://j.mp/3orqtGD
Benzinga,"Ionis appoints Eugene Schneider, M.D., as executive vice president and chief clinical development officer",https://www.benzinga.com/pressreleases/21/01/n19068836/ionis-appoints-eugene-schneider-m-d-as-executive-vice-president-and-chief-clinical-development-off,https://j.mp/2L2rDu1
Benzinga,Cadence Bancorporation Announces Select Estimated Fourth Quarter 2020 Financial Information,https://www.benzinga.com/pressreleases/21/01/b19068839/cadence-bancorporation-announces-select-estimated-fourth-quarter-2020-financial-information,https://j.mp/2L3QvSd
Benzinga,Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference,https://www.benzinga.com/pressreleases/21/01/g19068819/shattuck-labs-to-present-at-h-c-wainwright-bioconnect-2021-conference,https://j.mp/3q0OAws
